Rare autoantibody
Johnson & Johnson is committed to tirelessly pushing the boundaries of research to help develop innovative and transformational approaches to rare autoantibody-driven diseases, building on the ever-evolving understanding of the immune system.
Disease areas
Newsroom
See the latest rare autoantibody news by visiting our newsroom.
Featured resources
-
-
Patient Perspective: Karen Jones on the wAIHA patient experience and a path forward
Read moreYou are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
-
Listening and learning: Structuring clinical trials for patients living with warm autoimmune hemolytic anemia
Read more
You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
You are now leaving jnj.com
This link will take you to a website outside of Johnson & Johnson, which is governed by its own privacy policy and terms of use.
